SpineGuard announced its exclusive distribution agreement with XinRong Medical Group for PediGuard in China, Hong Kong and Macau.
Here are five insights:
1. SpineGuard develops and markets disposable medical devices designed to make spine surgery safer. The company's PediGuard probes incorporate dynamic surgical guidance technology, alerting surgeons in real time of potential vertebral cortical wall breaches.
2. China's spine market has become the second largest global market behind the U.S., and is expected reach $1 billion by 2019.
3. Influences of China's spine market growth include the age of population, increasing disease prevalence and treatment rates and growing affordability.
4. XinRong Medical Group provides innovative medical technology solutions in orthopedic surgery, neurosurgery, reconstructive surgery and minimally invasive therapy.
5. Pierre Jérôme, CEO and co-founder of SpineGuard, said, "Since its clearance by CFDA, numerous Chinese orthopedists and neurosurgeons have expressed a strong interest for our DSG technology."